🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How to be productive: Don’t do anything besides the task you set out to complete. That’s literally it.

The dream of waking up in the near future and being substantially younger at a cellular level is something I have the rare privilege to pursue each day. However, keeping this dream alive is contingent on the following (1) making timely and meaningful technical progress towards

Rare moments make you stop, stare, and imagine their future impact. I’m thrilled to share one of those moments from our work at Shift Bioscience. Over the last few years, the data often felt unreal. Today we compare the single-gene SB000 (Shift Bioscience 000) with the

Single-gene rejuvenation target promises safer cell age reversal Shift Bioscience #longevitybiotech #aging longevity.technology/news/single-ge…

Stay tuned for our LEVITY episode with Shift CEO Daniel Ives coming soon. And check out my interview with Daniel from last year: reachlevity.com/p/15-beyond-ya…

Genuine epigenetic rejuvenation in primary cells has long been the holy grail. A groundbreaking preprint reveals that over-expression of a single (secret) gene overcomes this barrier: greatly reduced age estimates across in fibroblasts and keratinocytes according to validated

「老化は治せる」——その最前線。 英国の研究チームが、たった1つの遺伝子で細胞を安全に最大13歳若返らせることに成功。 従来の研究には「山中因子」を使う技術がありましたが、細胞のガン化リスクがありました。今回の発見により、安全に若返る道が開かれたとのことです。 biorxiv.org/content/10.110…

Incredible Shift Bioscience reporting that they found a single factor that in cells can rejuvenate transcriptomic and epigenetic clocks without loss of cell identity. Amazing result, but the single factor is a secret, so others will not be able replicate their results.

🔥 Super cool research in longevity by Shift Bioscience! A new preprint ("A single factor for safer cellular rejuvenation") from Shift Bioscience reports a striking finding: a single gene, SB000, achieves robust cellular rejuvenation across two germ layers—fibroblasts and

Not dying is great. But have you ever considered sticking around for an astonishing future quite literally beyond your wildest imagination? Let’s solve aging and death at the root With the highest urgency And step into this astonishing future together

🆕 New LEVITY episode is live! Why tune in? Because a 24-person Cambridge startup may have beaten the billion-dollar OSK race with a single gene found by AI-powered virtual cells - and the early data look game-changing. (Links as always below.) Just about the hottest thing in

Thankyou Peter Ottsjö and Ingemar Patrick Linden for hosting me on the LEVITY LEVITY podcast to discuss our preprint 'A single factor for safer cellular rejuvenation' and beyond! youtube.com/watch?v=vdOVKZ…

Peter Ottsjö I prefer my partial reprogramming session without induced pluripotency 😅

Peter Ottsjö Best episode yet!

Detailed and enthusiastic discussion about Shift Bioscience preprint 'A single factor for safer cellular rejuvenation' between the two co-hosts on this podcast from Michael Chinen. Thank you for the feature! youtube.com/watch?v=ZjgzZE…

The main reason aging is not generally considered a disease is this: We don’t have a medicine for it yet